Carlos de Torre
Overview
Explore the profile of Carlos de Torre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tvarijonaviciute A, Ceron J, de Torre C, Ljubic B, Holden S, Queau Y, et al.
BMC Vet Res
. 2016 Sep;
12:211.
PMID: 27646300
Background: Approximately 20 % of obese dogs have metabolic disturbances similar to those observed in human metabolic syndrome, a condition known as obesity-related metabolic dysfunction. This condition is associated with...
2.
Tecles F, Tvarijonaviciute A, de Torre C, Carrillo J, Rubio M, Garcia M, et al.
Scand J Clin Lab Invest
. 2016 Apr;
76(4):324-30.
PMID: 27045801
Although saliva has esterase activity, this activity has not been characterized or studied in individuals subjected to physical stress. The aim of this report was to develop and validate an...
3.
Mayor-Lopez L, Tristante E, Carballo-Santana M, Carrasco-Garcia E, Grasso S, Garcia-Morales P, et al.
Transl Oncol
. 2014 Nov;
7(5):590-604.
PMID: 25389454
Nad(p)h: quinone oxidoreductase 1 (NQO1) enzyme and activity. However, colorectal LoVo cells still responded to both drugs in spite of having undetectable levels and activity of NQO1. Pharmacological and biologic...
4.
Fuentes-Rubio M, Ceron J, de Torre C, Escribano D, Gutierrez A, Tecles F
Can J Vet Res
. 2014 Apr;
78(2):127-32.
PMID: 24688174
The purpose of this research was to study changes in the salivary proteome of healthy pigs in stressful situations to identify any potential new salivary biomarker of stress. Three groups...
5.
Asensio-Lopez M, Sanchez-Mas J, Pascual-Figal D, de Torre C, Valdes M, Lax A
Free Radic Biol Med
. 2013 Nov;
67:19-29.
PMID: 24231192
The efficacy of doxorubicin (DOX) as an antitumor agent is greatly limited by the induction of cardiomyopathy, which results from mitochondrial dysfunction and iron-catalyzed oxidative stress in the cardiomyocyte. Metformin...
6.
Orenes-Pinero E, Hernandez-Romero D, de Torre C, Vilchez J, Martinez M, Romero-Aniorte A, et al.
Ann Med
. 2013 May;
45(4):341-7.
PMID: 23701180
Introduction: Aiming at identifying biomarkers for hypertrophic cardiomyopathy (HCM), the serum proteome was explored through a two-dimensional gel-based proteomic approach (2D-DIGE) coupled with mass spectrometry and database interrogation. Methods: Serum...
7.
Pinero A, de Torre C, Martinez-Escribano J, Campillo J, Canteras M, Nicolas F
World J Surg
. 2011 Dec;
36(3):579-85.
PMID: 22205107
Background: There is some controversy in the literature regarding the possible prognostic value of cases of multiple lymphatic basin drainage (MLBD). The purpose of this work was to study the...
8.
Gonzales D, de Torre C, Wang H, Devor C, Munson P, Ying S, et al.
Proteomics
. 2010 Nov;
10(23):4270-80.
PMID: 21089047
We hypothesized that invasive pulmonary aspergillosis (IPA) may generate a distinctive proteomic signature in plasma and bronchoalveolar lavage (BAL). Proteins in plasma and BAL from two neutropenic rabbit models of...
9.
de Torre C, Martinez-Escribano J
Exp Dermatol
. 2010 Jul;
19(8):e333-5.
PMID: 20653773
We have examined alterations in the cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase 4 (CDK4), major melanoma predisposing genes, in a Spanish melanoma-prone population comprising 61 patients from 45...
10.
de Torre C, Garcia-Casado Z, Martinez-Escribano J, Botella-Estrada R, Banuls J, Oliver V, et al.
Melanoma Res
. 2010 Jun;
20(4):342-8.
PMID: 20539244
We explored the presence of germline alterations in CDK4 exon 2, CDKN2A and MC1R in a hospital-based study of 89 melanoma cases from 89 families with at least two members...